Related by context. All words. (Click for frequent words.) 74 bilateral oophorectomy 73 salpingo oophorectomy 71 risk reducing salpingo 71 prophylactic mastectomy 70 atypical hyperplasia 70 ALND 70 premenopausal 70 prophylactic mastectomies 70 ovariectomy 69 endometrial carcinoma 68 postoperative mortality 68 advanced adenoma 68 prophylactic oophorectomy 67 orchiectomy 67 ductal breast cancer 67 axillary lymph node dissection 67 endometrial hyperplasia 67 endometrial cancers 67 GnRH agonists 67 preventive mastectomies 66 orchidectomy 66 androgen deprivation 66 BRCA gene mutations 66 undergone hysterectomy 66 carotid stenosis 66 radical nephrectomy 66 BRCA1 mutations 66 preventive mastectomy 66 axillary dissection 66 sentinel node biopsy 66 invasive carcinoma 66 cystectomy 66 lobular breast cancer 66 polyp recurrence 66 adenoma 66 BRCA mutations 66 premenopausal breast cancer 65 contralateral breast cancer 65 subclinical hypothyroidism 65 adjuvant radiotherapy 65 leiomyomas 65 vaginal hysterectomy 65 BRCA2 mutation carriers 65 undergoing radical prostatectomy 65 pneumonectomy 65 tibolone 65 varicocele 65 lymph node removal 65 hormone therapy estrogen 64 axillary lymph nodes 64 advanced adenomas 64 pre menopausal 64 Ovary removal 64 endometrial cancer 64 beta blocker therapy 64 adjuvant radiation 64 symptomatic fibroids 64 undergoing hysterectomy 64 vertebral fracture 64 nephrectomy 64 sentinel lymph node biopsy 64 nerve sparing 64 ductal carcinomas 64 pelvic lymphadenectomy 64 nonmelanoma skin cancers 64 lobular cancer 63 BRCA2 mutations 63 perioperative mortality 63 invasive breast cancer 63 adrenalectomy 63 postoperative morbidity 63 preterm deliveries 63 BRCA1 mutation carriers 63 β blockers 63 polycystic ovary syndrome PCOS 63 perioperative morbidity 63 BRCA mutation 63 lymphadenectomy 63 perioperative complications 63 elevated CRP 63 SLNB 63 carotid endarterectomy 63 contralateral breast 63 abnormal mammogram 63 BRCA mutation carriers 63 atypia 63 esophagectomy 63 tamoxifen therapy 63 ovulatory cycles 63 thyroidectomy 63 hepatectomy 63 TURP 63 hormonal therapy 63 nonmelanoma skin cancer 63 myomectomy 63 breast carcinoma 63 Adjuvant chemotherapy 63 irregular menstrual cycles 63 colorectal adenoma 63 postmenopausal hormone therapy 63 mammographic density 63 bilateral prophylactic mastectomy 63 Hysterectomy 63 adenomatous polyps 63 pCR 63 spontaneous preterm delivery 63 cytoreductive surgery 62 operable breast cancer 62 thromboembolism 62 abdominal hysterectomy 62 prostate TURP 62 postoperative atrial fibrillation 62 serum testosterone levels 62 cryptorchidism 62 benign breast 62 BRCA2 carriers 62 colorectal polyps 62 distant metastases 62 premenopausal women 62 GnRH agonist 62 recurrent VTE 62 ovaries removed 62 parathyroidectomy 62 thyroid nodules 62 testosterone supplementation 62 preoperative chemotherapy 62 curative resection 62 postoperative complications 62 LNG IUS 62 estrogen progestin therapy 62 prostate cancer CaP 62 varicoceles 62 lobular carcinoma 62 postmenopausal breast cancer 62 gastrectomy 62 subclinical hyperthyroidism 62 folate supplementation 62 estrogen receptor negative 62 atypical ductal hyperplasia 62 breast conserving 62 partial nephrectomy 62 abnormal mammograms 62 osteopenic 62 BRCA2 mutation 62 Lumpectomy 62 myomas 61 endometriosis ovarian cysts 61 fibroids endometriosis 61 ovulation induction 61 Radical prostatectomy 61 venous thrombosis 61 CIN3 61 undergone radical prostatectomy 61 asymptomatic carotid stenosis 61 breast cancer recurrence 61 precancerous cervical 61 ductal cancer 61 nodal metastases 61 premature menopause 61 postmenopausal 61 androgen ablation 61 axillary node dissection 61 gallstone disease 61 pathologic fractures 61 clinically insignificant 61 total thyroidectomy 61 primary ovarian insufficiency 61 adnexal mass 61 nephron sparing surgery 61 postoperative chemotherapy 61 lipid lowering therapy 61 malignant polyps 61 polycystic ovary syndrome 61 epithelial ovarian cancer 61 menopausal hormone therapy 61 subtrochanteric 61 nonvertebral fractures 61 uterine tumors 61 postmenopausal hormones 61 axillary node 61 contralateral prophylactic mastectomy 61 deep venous thrombosis 61 uterine cancers 61 ovary removal 61 neoadjuvant therapy 61 Subgroup analyzes 61 surgically induced 61 PSADT 61 VUR 61 PSA screening 61 epithelial ovarian 61 advanced neoplasia 61 preterm delivery 61 polycystic ovaries 61 HoLEP 61 lymph node dissection 61 ovarian hormones 61 neoadjuvant chemotherapy 61 aromatase inhibitor therapy 61 benign growths 61 radioiodine therapy 61 chlamydial infection 60 hormone therapy 60 ovarian stimulation 60 axillary nodes 60 extrapleural pneumonectomy 60 neoadjuvant 60 patients undergoing CABG 60 Heavy menstrual bleeding 60 inguinal hernia repair 60 colectomy 60 incomplete revascularization 60 thromboembolisms 60 hysterectomy 60 ASCUS 60 estrogen therapy 60 adenoma recurrence 60 parous women 60 thrombotic events 60 bowel resection 60 PSA velocity 60 oncologic outcomes 60 subfertility 60 androgen deprivation therapy 60 multivessel disease 60 uterine fibroid embolization 60 nonvertebral fracture 60 postoperative complication 60 mutated BRCA1 60 postoperative pulmonary 60 anovulatory infertility 60 nonoperative 60 CHD mortality 60 radical cystectomy 60 endarterectomy 60 chorioamnionitis 60 cytoreduction 60 paroxysmal AF 60 serum PSA 60 prostate carcinoma 60 reoperations 60 postoperative AF 60 microvascular disease 60 bilateral salpingo oophorectomy 60 cranial irradiation 60 hip BMD 60 pancreatic resection 60 fibroadenomas 60 undergone hysterectomies 60 BRCA gene mutation 60 breast endometrial 60 singleton pregnancy 60 thyroid hormone levels 60 colorectal neoplasia 60 pyelonephritis 60 endometrial thickness 60 adjuvant therapy 60 catheter angiography 60 colon tumors 60 hormone receptor negative 60 HNSCC 60 hormonal treatments 60 atrophic gastritis 60 pancreatic adenocarcinoma 60 colorectal neoplasms 60 conjugated equine estrogen 60 localized prostate cancer 60 serum phosphate 60 VCUG 60 bisphosphonate therapy 60 serum estradiol 60 baseline mammogram 60 hepatic resection 60 postmenopausal hormone replacement 60 epigenetic changes 60 thromboembolic disease 60 cholecystectomy 60 sentinel nodes 60 abnormal Pap test 60 coronary arteriography 60 surgical revascularization 60 ovarian carcinoma 60 exemestane 60 abnormal Pap smears 60 colorectal polyp 60 adenoidectomy 60 intestinal polyps 60 chemoradiotherapy 60 biochemical recurrence 59 repigmentation 59 perimenopausal women 59 neoadjuvant radiation 59 Surgical excision 59 Postmenopausal 59 endometrial 59 estrogen deficiency 59 recurrent ovarian 59 meniscectomy 59 anastrozole 59 benign proliferative breast 59 noncarriers 59 sacrocolpopexy 59 knee OA 59 lymph node involvement 59 surgical biopsies 59 intravenous bisphosphonates 59 calcium supplementation 59 spontaneous preterm birth 59 vitamin D supplementation 59 pre cancerous polyps 59 intraoperative complications 59 Complication rates 59 dysfunctional voiding 59 femoral shaft fractures 59 haemorrhagic stroke 59 CLA supplementation 59 osteoporotic fractures 59 androgen deficiency 59 reoperation 59 precursor lesions 59 benign lesions 59 recurrent miscarriage 59 pathologic fracture 59 thoracoscopic lobectomy 59 metastatic lung cancer 59 invasive ductal 59 screening colonoscopy 59 PSA nadir 59 partial hysterectomy 59 precancerous polyp 59 serum creatinine levels 59 MetS 59 renal cell carcinomas 59 placenta praevia 59 liver biopsies 59 radical retropubic prostatectomy 59 laparoscopically assisted 59 Hurthle cell 59 infantile hemangiomas 59 serum testosterone 59 gestational hypertension 59 androgen suppression therapy 59 histologically confirmed 59 congenital abnormalities 59 Postoperative complications 59 coronary angiography 59 SLN biopsy 59 femoral neck BMD 59 endometrial biopsy 59 mammary tumors 59 mammographic screening 59 colorectal liver metastases 59 liver resection 59 definite stent thrombosis 59 hamartoma 59 biochemical relapse 59 urothelial carcinoma 59 antibiotic prophylaxis 59 pulmonary metastases 59 liver metastasis 59 chemoradiation 59 urinary symptoms 59 breast tenderness 59 peritoneal cancer 59 adjuvant chemotherapy 59 postmenopausal estrogen 59 lumbar disk herniation 59 bowel cancers 59 benign nodules 59 testicular tumors 59 locoregional recurrence 59 colorectal adenomas 59 surgical excision 59 postoperative radiotherapy 59 post thrombotic syndrome 59 atherogenic dyslipidemia 59 nonpregnant women 59 transurethral resection 59 postoperative infections 59 thromboembolic events 59 flutamide 59 coronary calcification 59 ICD implantation 59 tumor recurrence 59 tumor resection 59 androgen suppression 59 renal tumors 59 masectomy 59 slow metabolizers 59 vulvar intraepithelial neoplasia 59 chronic prostatitis 59 osteoporotic 59 Cesarean deliveries 59 OPCAB 59 adjuvant hormonal therapy 59 medically inoperable 59 endogenous estrogen 59 intestinal metaplasia 59 bowel polyps 59 fetal malformations 59 multiple gestations 58 nonoperative treatment 58 underwent radical prostatectomy 58 radical prostatectomy RP 58 polycystic ovarian syndrome PCOS 58 hip fracture 58 pre cancerous lesion 58 breast cancer recurrences 58 mastectomy 58 precancerous condition 58 paclitaxel eluting stents 58 vertebral fractures 58 cerebral infarction 58 hamartomas 58 osteosarcomas 58 CVD mortality 58 EBRT 58 recurrent UTI 58 prostatectomy 58 sleeve lobectomy 58 hsCRP levels 58 hormonal therapies 58 bilateral mastectomy 58 biliopancreatic diversion 58 serum clusterin levels 58 multivariate logistic regression 58 BRCA2 gene mutation 58 selenium supplementation 58 azoospermia 58 ovaries surgically 58 serum calcium levels 58 coronary revascularization 58 atypical fractures 58 pyloric stenosis 58 cilostazol 58 radical mastectomy 58 BENICAR HCT 58 anovulatory 58 estrogen receptor positive 58 tamoxifen 58 underwent hysterectomy 58 hydronephrosis 58 conventional angiography 58 pelvic prolapse 58 antithrombotic therapy 58 elective PCI 58 radical hysterectomy 58 immunosuppressive medications 58 metastatic RCC 58 NMIBC 58 cerebral microbleeds 58 micrometastases 58 cancerous breast 58 nulliparous women 58 colorectal cancer incidence 58 postpartum hemorrhage 58 adenomas 58 colon resection 58 folate intake 58 HGPIN 58 multivariate Cox 58 adenotonsillectomy 58 transfusion syndrome 58 trabeculectomy 58 HER2 positive cancers 58 R0 resection 58 nulliparous 58 Kaplan Meier analysis 58 Papillary 58 femoral neck fractures 58 testicular cancers 58 knee osteoarthritis 58 core needle biopsy 58 DXA scan 58 AVODART 58 molar pregnancy 58 PCa 58 LHRH receptor positive 58 malignant lesions 58 Endometrial 58 mycophenolate mofetil 58 thyrotropin levels 58 hematopoietic cancers 58 strontium ranelate 58 detrusor overactivity 58 vesicoureteral reflux 58 dietary calcium intake 58 myelomeningocele 58 breast conserving lumpectomy 58 amenorrhoea 58 pelvic organ prolapse 58 venous thromboembolism 58 radical prostatectomy 58 EUS FNA 58 precocious puberty 58 thyroid dysfunction 58 postoperative infection 58 ovulatory dysfunction 58 aromatase inhibitors AIs 58 epidural analgesia 58 fundoplication 58 luteal 58 multivariate analyzes 58 cervical carcinoma 58 ovarian cysts 58 thrombophilia 58 retransplantation 58 hypogonadal men 58 thromboembolic 58 Uterine fibroids 58 nonsurgical treatments 58 myoma 58 progestins 58 glandular tissue 58 Hashimoto thyroiditis 58 periprocedural MI 58 naturally occurring estrogen 58 serum uric acid 58 vasomotor symptoms 58 bladder cancers 58 Hysterectomies 58 Amniocentesis 58 premature ovarian 58 nodal metastasis 58 lung metastasis 58 Caesarean deliveries 58 NNRTI resistance 57 ductal lobular 57 neurodevelopmental outcomes 57 chronic prostatitis chronic 57 precancerous cervical lesions 57 LAGB 57 left ventricular dysfunction 57 multimodality therapy 57 metachronous 57 situ DCIS 57 postoperative delirium 57 underwent coronary angiography 57 benign prostatic hypertrophy 57 duodenal switch 57 carotid surgery 57 bone metastasis 57 HER2 expression 57 hormone deprivation 57 meningioma 57 underwent brachytherapy 57 mucinous 57 AMOR IPAT 57 prostate pancreatic 57 multivariable analysis 57 HER2 overexpression 57 shorter telomeres 57 telomere lengths 57 allogeneic stem cell 57 lymph node metastases 57 leiomyoma 57 serous ovarian cancer 57 placenta accreta 57 noncardiac surgery 57 reinfarction 57 hypertrophic scars 57 post menopausal 57 urothelial cancer 57 cerebral angiography 57 Invasive Breast Cancer 57 neoplasias 57 revascularization procedure 57 FGFR2 gene 57 glomerular filtration rate 57 situ LCIS 57 Gynecomastia 57 endocrine therapies 57 spine fractures 57 progesterone receptor negative 57 lipid lowering drugs 57 OAB symptoms 57 basal cell nevus syndrome 57 normotensive 57 undergo radical prostatectomy 57 transferrin saturation 57 postmenopausal hormone 57 androgen depletion 57 binary restenosis 57 distal colon cancer 57 squamous cell cancers 57 STRIDE PD 57 CMV disease 57 bacterial vaginosis 57 chemoradiation therapy 57 urolithiasis 57 skin sparing mastectomy 57 invasive ductal breast cancer 57 coronary revascularization procedures 57 preoperative MRI 57 carotid IMT 57 grade dysplasia 57 BMD measurements 57 revascularization procedures 57 cervical lesions 57 Subgroup analysis 57 pulmonary artery banding 57 poorer prognosis 57 carcinoid tumor 57 macrovascular 57 hip resurfacing arthroplasty 57 T1DM 57 abdominal ultrasounds 57 prior nephrectomy 57 undergo mastectomy 57 GIST tumors 57 peritoneal carcinomatosis 57 statin medications 57 thigh circumference 57 NSTE ACS 57 ovarian malignancy 57 adenomatous 57 MMSE scores 57 poor metabolizers 57 ticlopidine 57 clinically detectable 57 Multivariate analyzes 57 unexplained infertility 57 acute aortic dissection 57 pelvic lymph nodes 57 median sternotomy 57 periprocedural 57 perinatal outcomes 57 Sentinel node biopsy 57 underwent resection 57 asymptomatic PAD 57 Postmenopausal Women 57 subclinical atherosclerosis 57 fibroma 57 oestradiol 57 uterine ovarian 57 corticosteroid therapy 57 ovulatory infertility 57 clinically localized prostate 57 contrast induced nephropathy 57 loop diuretics 57 familial adenomatous polyposis 57 sFlt 1 57 uterine rupture 57 RYGB 57 fibrinolysis 57 breast abscesses 57 radial artery grafts 57 fragility fracture 57 univariate analysis 57 HER2 positive tumors 57 caesarean delivery 57 EXJADE 57 virologic failure 57 acetabular dysplasia 57 pre cancerous growths 57 lipomas 57 extracolonic findings 57 urinary tract symptoms LUTS 57 bone scintigraphy 57 papillomas 57 undergo lumpectomy 57 bypass grafting 57 reperfusion therapy 57 acetabular fracture 57 intact parathyroid hormone 57 invasive diagnostic 57 carotid plaque 57 bilateral orchiectomy 57 basal cell carcinomas 57 antiplatelet drugs 57 prostate biopsy 57 neural tube defect 57 liver transplant recipients 57 pT2 57 NATRECOR ® 57 hepatic metastases 57 total knee arthroplasty 57 serum thyroglobulin 57 antireflux surgery 57 femur fractures 57 breast asymmetry 57 breast uterine 57 confidence interval #.#-#.# 57 calculi 57 ambiguous genitalia 57 BRCA carriers 57 PHPT 57 CC genotype 57 colon polyps 57 osteoporotic compression fractures 57 singleton pregnancies 57 rebleeding 57 lung metastases 57 glycated hemoglobin levels 57 coronary blockages 57 MACCE 57 ALA PDT 57 upper gastrointestinal bleeding 56 ankle arthrodesis 56 osteoporotic fracture 56 BRCA1 56 thromboprophylaxis 56 selenium intake 56 microvascular complications 56 clodronate 56 mastectomies 56 lumpectomies 56 hydroxychloroquine 56 Cystectomy 56 risedronate 56 epididymitis 56 TP# mutations 56 estrogen progestin combination 56 neurodevelopmental outcome 56 preventative mastectomy 56 neoplasia 56 artery embolization 56 antioxidant supplementation 56 revascularization 56 lymphocytosis 56 cranial radiation 56 endometrial lining 56 histologic subtype 56 carotid endarterectomy CEA 56 antigen PSA 56 carotid artery stenting 56 LUTS 56 severe renal impairment 56 placental malaria 56 postmenopausal women 56 congenital malformations 56 hypospadias 56 basal cell cancers 56 ovarian hyperstimulation syndrome OHSS 56 hydroxyvitamin D levels 56 anal cancers 56 mutated K ras 56 fibrocystic changes 56 sentinel node 56 mammographic breast density 56 neurodevelopmental impairment 56 radiographic findings 56 basal cell carcinoma BCC 56 pelvic lymph node dissection 56 multivariable adjusted 56 platelet reactivity 56 lichen planus 56 varices 56 femoral neck fracture 56 intima media thickness 56 hormone receptor positive 56 penetrance 56 mitral regurgitation 56 #F FDG PET 56 endometrial ablation 56 deCODE BreastCancer TM 56 TACE 56 total abdominal hysterectomy 56 cesarean delivery 56 colonoscopic 56 lumbar disc herniation 56 premalignant 56 spontaneous regression 56 noncardiovascular mortality 56 ovarian 56 elevated LDH 56 thrombotic complications 56 atherosclerotic renal artery stenosis 56 external beam radiotherapy 56 endophthalmitis 56 moderate renal impairment 56 testicular germ cell 56 placebo dexamethasone 56 symptomatic VTE 56 androgen excess 56 percutaneous nephrolithotomy 56 LHRH agonist 56 overactive bladder symptoms 56 Wilms tumors 56 prostate cancer CRPC 56 obese postmenopausal 56 recurrent venous thromboembolism 56 hemoglobin A1c levels 56 GISTs 56 elevated LDL cholesterol 56 hyperbilirubinemia 56 renal dysfunction 56 BRCA1 mutation 56 atherosclerotic progression 56 ruptured aneurysms 56 #.#ng/ml 56 coronary angiogram 56 Endometrial ablation 56 cystic lesions 56 endoscopic ultrasonography 56 retroperitoneal 56 H. pylori eradication 56 frequently benign tumor 56 urine cytology 56 hirsutism 56 cTnT 56 teriparatide 56 colon rectal 56 T2DM 56 nonfasting triglyceride levels 56 luteal phase 56 transabdominal 56 biventricular repair 56 obstetric complications 56 osteoarthritic 56 Uterine cancer 56 computed tomography scans 56 sonographic findings 56 amenorrhea 56 tubal 56 postmenopause 56 radiochemotherapy 56 ductal 56 debulking surgery 56 colorectal cancer CRC 56 Carotid stenting 56 morphometric vertebral fractures 56 comorbid conditions 56 systolic hypertension 56 nondepressed 56 neurologic outcomes 56 IV bisphosphonates 56 removed laparoscopically 56 letrozole 56 mild gestational diabetes 56 endocrine therapy 56 adenocarcinomas 56 ovarian function 56 lumbar spine BMD 56 carbohydrate intolerance 56 glycoprotein IIb IIIa inhibitors 56 HbA1C levels 56 phytoestrogen intake 56 ductal carcinoma 56 preoperative radiotherapy 56 locoregional 56 colorectal tumors 56 metaplasia 56 fallopian tube cancers 56 nondiabetic patients 56 nodal dissection 56 thymectomy 56 univariate analyzes 56 resections 56 progestogen 56 adrenal function 56 bone resorption 56 precancerous tumors 56 carotid artery stenting CAS 56 repeat revascularization 56 parous 56 persistent pulmonary hypertension 56 CMV infection 56 gestational diabetes mellitus 56 TRUS biopsy 56 antihypertensive therapy 56 elevated triglyceride levels 56 venous blood clots 56 uterine cancer 56 mIU L 56 Flexi Scope 56 euthyroid 56 PASI scores 56 Asymptomatic 56 skeletal metastases 56 myocardial viability 56 transaminase levels 56 benign lesion 56 heavy menstrual bleeding 56 plasma homocysteine levels 56 underwent CABG 56 invasive lobular carcinoma 56 stress incontinence 56 Breast conserving 56 variceal hemorrhage 56 ductal lavage 56 resectable 56 cardioembolic stroke 56 univariate 56 Leitzmann 56 diverticular bleeding 56 ICDs implanted 56 atherothrombotic events 56 overt hepatic encephalopathy HE 56 chemopreventive agent 56 carotid endarterectomy surgery 56 protein excretion 56 tumor histology 56 upper endoscopy 56 esophageal resection 56 adenomyosis 56 fasting insulin 56 baseline HbA1c 56 menstrual bleeding 56 lordosis 56 hereditary breast cancer 56 dose ionizing radiation 56 liver metastases 56 impair fertility 56 Mitomycin C 56 IUGR 56 SUVmax 56 nonfatal MI 56 pre eclamptic 56 laparoscopic adjustable gastric banding 56 SHBG levels 56 colon adenomas 56 FASLODEX 56 reinterventions 56 anti androgen 55 CIN2 + 55 Chlamydia infection 55 systemic corticosteroid 55 hallux valgus 55 specific antigen PSA 55 keloid scarring 55 recurrent miscarriages 55 revascularizations 55 hormone therapy HT 55 RALP 55 prostate adenocarcinoma 55 hippocampal volume 55 cryptogenic stroke 55 overt hypothyroidism 55 pancreatic lung 55 noncardiac 55 incidentalomas 55 glomerular filtration 55 KRAS mutations 55 TP# mutation 55 Coronary artery bypass graft 55 venous thromboembolisms 55 FDG PET scans 55 neurologic complications 55 MGUS 55 total knee arthroplasties 55 Contralateral 55 ultrasonographic 55 juvenile idiopathic arthritis 55 carotid plaques 55 sympathectomy 55 CYPHER Stent 55 seminoma 55 mL/min/#.# m 2 55 screening colonoscopies 55 arterial stiffening 55 ELBW infants 55 Thal Dex 55 venous thromboembolic events 55 Digital Mammographic Imaging 55 loop diuretic 55 complete cytogenetic response 55 cytoreductive nephrectomy 55 hypogonadal 55 urinary leakage 55 Mastectomy 55 sonographic evaluation 55 K ras mutations 55 groin hernias 55 NP CRNs 55 TZDs 55 Breast Cancer Risk 55 teratogenic 55 truncal 55 arterial thickening 55 BRCA testing 55 Nonsurgical 55 premalignant lesions 55 cell carcinomas 55 endosonography 55 HNPCC 55 excisional biopsy 55 uterine fibroid embolization UFE 55 serum selenium 55 endometriosis 55 familial hypercholesterolemia 55 precancer 55 femoral fracture 55 fibrocystic disease 55 retrograde ejaculation 55 genes BRCA1 55 hypercalcemia 55 premenstrual syndrome PMS 55 elevated hsCRP 55 pre operatively 55 antiandrogen 55 amyloid deposition 55 HER2 negative 55 breast biopsies 55 primary percutaneous coronary 55 ADPKD 55 fetal chromosomal 55 angiographic restenosis 55 intensive statin therapy